Search results
Archery: Bhajan Kaur in pre-quarters; Ankita, Dhiraj exit
rediff.com· 2 days agoIndian archer Bhajan Kaur notched twin victories to advance to the women's individual...
Wasteful India secure passage into hockey quarter-finals
Hindustan Times· 2 days agoHarmanpreet duly capitalised on a penalty stroke in the 11th minute with a low shot into the boards...
What Happened To Tucker McCall On Young and the Restless?
SOAPHUB· 2 days agoThank you for your time on #YR again you’re going to be so missed! Fans, we love you so much & wish...
Is Keanu Reeves' Constantine 2 Happening? Here's What Akiva Goldsman Has To Say
Pinkvilla· 2 days agoDuring this year’s San Diego Comic-Con panel discussion, Producers on Producing by Collider’s...
Gary Moore’s “Showbiz Blues” 1961 Gibson SG Jr is heading for auction and it is a TV Yellow unicorn
MusicRadar· 2 days agoThis might well be one of the coolest guitars ever, but it is definitely the coolest you will see...
“We were solid, bungling amateurs on little mixing desks”: D:Ream on their road to platinum success...
MusicRadar· 2 days agoIt was really difficult, back then, to get filters to work, especially on the [Yamaha] DX7....
Deadpool & Wolverine is the epitome of fan service. Here’re the major easter eggs and surprise clues...
Business Insider India· 2 days agoFansDisclaimer: If you are a superhero fanatic who has been disappointed with the content out there...
Inflation, immigration worries push some Nevada Hispanics toward the GOP
South Carolina Daily Gazette· 2 days agoLAS VEGAS — Here in Nevada, where a larger share of Hispanic people have made it into the middle...
Metal commodities likely to remain soft going forward: Deven Choksey - ET Auto
The Economic Times· 2 days ago"So, to a greater extent, the crude as a territory and metal along with particularly, they are likely to remain softer going forward as well," says Deven Choksey, MD, DRChoksey FinServ Pvt.
Pfizer quits Duchenne gene therapy, lays off staff following study setback
BioPharma Dive· 2 days agoBut it’s also cut back on early-stage gene therapy research and saw testing of its Duchenne candidate stalled...the drug’s performance and historical data. “We believe the ...